О себе
Neil Miller, Ph.D., is a UK biotech executive and organic chemist best known as co-founder and CEO of NRG Therapeutics, a neuroscience company developing mitochondrial therapeutics for Parkinson's and ALS/MND. Before NRG, he served as CSO and then CEO of Auspherix, and earlier spent 18 years at GlaxoSmithKline in senior scientific and leadership roles, including work in neuroscience R&D in Singapore.
Области интересов
biotechneuroscienceneurodegenerationParkinson's diseaseALS/MNDmitochondrial biologydrug discoverysmall-molecule therapeutics